Cocrystal Pharma, Inc. (COCP)
NASDAQ: COCP · Real-Time Price · USD
1.110
-0.030 (-2.63%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Cocrystal Pharma Market Cap
Cocrystal Pharma has a market cap or net worth of $21.38 million as of August 28, 2026. Its market cap has increased by 34.48% in one year.
Market Cap
21.38M
Enterprise Value
20.55M
1-Year Change
34.48%
Ranking
Category
Stock Price
$1.11
ChartMarket Cap Chart
Since March 12, 2018, Cocrystal Pharma's market cap has decreased from $115.30M to $21.38M, a decrease of -81.46%. That is a compound annual growth rate of -18.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 21.38M | 58.39% |
| Dec 31, 2025 | 13.50M | -34.47% |
| Dec 31, 2024 | 20.60M | 17.71% |
| Dec 29, 2023 | 17.50M | 10.06% |
| Dec 30, 2022 | 15.90M | -74.92% |
| Dec 31, 2021 | 63.40M | -31.97% |
| Dec 31, 2020 | 93.20M | 435.63% |
| Dec 31, 2019 | 17.40M | -83.84% |
| Dec 31, 2018 | 107.70M | -6.59% |
| Mar 12, 2018 | 115.30M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cellectar Biosciences | 24.01M |
| Polyrizon | 23.96M |
| Cerenome | 23.53M |
| Genenta Science | 23.37M |
| Dyadic International | 23.29M |
| Jasper Therapeutics | 23.27M |
| Niki BioSolutions | 22.16M |
| Allarity Therapeutics | 21.96M |